Back to Shared Resources
-
Research -
Patient Care -
Education -
People -
Shared Resources -
Cancer Data Science -
Cell & Tissue Imaging -
Epigenetics & Epigenomics -
Experimental Irradiation -
Flow Cytometry -
Health Communications -
Immune Monitoring -
Liquid Biopsy -
Pharmacokinetics -
Preclinical Molecular Imaging -
Protoemics Resource Facility -
Single Cell Spatial Analysis -
Structure & Drug Screening -
Tissue & Molecular Pathology -
Transgenic Animal Models
-
-
About -
Forbes Institute for Cancer Discovery
Structure & Drug Screening
Project-Specific Entry Points for Structure and Drug Screening Resources
Service Highlights
- Single entry point for technical expertise and equipment for using in academic drug discovery
- Creation and execution of translational cancer drug discovery project plans that start with the end in mind
- Cost savings due to streamlined structure and execution
- Expert consulting in structural biology, target/pathway identification, protein production, and assay development
- High throughput screening, structure-based drug design and initial medicinal chemistry
Our team has a strong mission to support and enhance cancer research projects through collaborative efforts. Our goals include:
- Support early stage, cancer research discovery projects in structural biology, target discovery, small molecule screening and medicinal chemistry using unique technical expertise and specialized equipment.
- Support enhanced pre-clinical efforts to develop compounds and compound classes that show considerable promise and potential in early stage research efforts.
If you have questions about services related to structure and drug screening, please contact our team:
Co-directors:
Andrew Alt, PhD, Center for Chemical Genomics
Janet Smith, PhD., Center for Structural Biology
Managers:
Jeanne Stuckey, PhD, Center for Structural Biology
Locations:
Life Sciences Institute, 210 Washtenaw, Room 3358
College of Pharmacy, 4562 CC Little, 428 Church St.
Phone: 734-647-8098